Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China · Delayed Price · Currency is CNY

18.57

+0.18 (0.98%)

Aug 20, 2026, 3:04 PM CST

SHE:300534 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	843.87	886.96	1,043	1,080	799.68	287.81
Revenue Growth	-20.56%	-14.92%	-3.48%	35.06%	177.85%	12.91%
Gross Profit	563.23	603.55	751.13	693.26	458.06	92.33
Operating Income	78.73	87.47	96.02	81.82	56.31	-9.31
Net Income	49.37	43.95	24.48	61.65	38.79	-9.11
Earnings Per Share	0.16	0.14	0.08	0.20	0.13	-0.03
EPS Growth	129.14%	79.55%	-60.28%	58.87%	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
China	874.83	1,034	1,071	789.4	275.55
Foreign	12.13	8.4	8.63	10.28	12.26
Total	886.96	1,043	1,080	799.68	287.81

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	234.61	241.33	310.02	288.95	369.24	99.12
Total Debt	105.52	132.51	114.68	144.54	-	-
Net Cash (Debt)	129.09	108.82	195.34	144.4	369.24	99.12
Net Cash Growth	-25.80%	-44.29%	35.27%	-60.89%	272.52%	105.97%
Net Cash Per Share	0.43	0.36	0.64	0.48	1.22	0.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	29.85	-6.54	214.92	96.53	267.44	51.13
Capital Expenditures	-44.61	-43.36	-77.69	-126.36	-25.41	-0.41
Free Cash Flow	-14.76	-49.9	137.23	-29.83	242.03	50.72
Free Cash Flow Growth	-	-	-	-	377.18%	103.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	66.74%	68.05%	72.05%	64.19%	57.28%	32.08%
Operating Margin	9.33%	9.86%	9.21%	7.58%	7.04%	-3.24%
Pretax Margin	10.61%	9.15%	9.76%	8.98%	8.27%	-1.65%
Profit Margin	5.85%	4.96%	2.35%	5.71%	4.85%	-3.16%
FCF Margin	-1.75%	-5.63%	13.16%	-2.76%	30.27%	17.62%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.040	0.040	0.040	0.020
Dividend Per Share Growth	0%	0%	100.00%	-
Dividend Yield	0.22%	0.42%	0.46%	0.21%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	114.07	65.43	107.82	48.57	69.37	-
P/FCF Ratio	-	-	19.23	-	11.12	88.04
PS Ratio	6.68	3.24	2.53	2.77	3.37	15.51